German drugmaker Bayer (BAYN: DE) has signed a global licensing agreement with China-based Puhe BioPharma, gaining exclusive ...

French biotech company Transgene (Euronext Paris: TNG) has reported its 2024 financial results and provided updates on its cancer immunotherapy pipeline. The company highlighted significant progress ...

Danish cancer specialist Genmab today announced that the Japanese Ministry of Health, Labor and Welfare has approved Tivdak ...

Under President Donald Trump’s new Secretary of Health and Human Services (HHS), the prominent vaccine sceptic Robert Francis ...

Cambridge, USA-based RNS specialist Wave Life Sciences (Nasdaq: WVE) has announced positive data from the Phase II FORWARD-53 trial of WVE-N531, which is an exon skipping oligonucleotide being ...

Genetic diseases company BridgeBio Pharma has announced that the Japanese Ministry of Health, Labor and Welfare has approved ...

UK-based specialty pharma Kelso Pharma, which is backed by private equity investor Apposite Capital, announced that it has ...

The US Senate has confirmed President Donald Trump’s nominees to lead two of the country’s top health agencies, approving ...

US biotech Equillium reported Thursday that its lead drug candidate itolizumab failed to meet the main objective in a Phase ...

Swiss ophthalmic drug company Alcon (SIX/NYSE: ALC) today announced it has acquired a majority interest in Aurion Biotech, a ...

San Francisco-based epigenetic editing company Epicrispr Biotechnologies has secured $68 million in the first close of its ...

German family-owned pain specialist Grünenthal today published its 2024 financial results, marking a year of impressive ...